Archive | June, 2010
Mylotarg (gemtuzumab ozogamicin): Market Withdrawal
Drug failed to demonstrate clinical benefit to patients enrolled in trials.
Continue reading...Magic Power Coffee: Undeclared Drug Ingredient
21. June 2010
Comments Off
Product marketed as a dietary supplement for sexual enhancement contains the drug ingredient hydroxythiohomosildenafil, a chemical that may interact with prescription nitrates, and cause dangerously low blood pressure.
Continue reading...Tamiflu: Counterfeit Product Sold on Internet
17. June 2010
Comments Off
Potentially harmful product represented as “Generic Tamiflu”- tests revealed product does not contain oseltamivir, but cloxacillin, an antibiotic.
Continue reading...Vitamin D Supplement Products: Medication Use Error
15. June 2010
Comments Off
Some liquid Vitamin D supplement products are sold with droppers that could allow parents to accidentally give harmful amounts of Vitamin D to their infant.
Continue reading...Hospira Brand Liposyn and Propofol: Recall
10. June 2010
Comments Off
Injectable products may contain particulate matter.
Continue reading...Defibtech DBP-2800 Battery Packs used in Lifeline AED and ReviveR AED: Recall
9. June 2010
Comments Off
AED may falsely detect an error condition during charging for a shock, then cancel charge and not provide therapy, when used with an affected battery pack.
Continue reading...Counterfeit Polypropylene Surgical Mesh: Initial Communication
8. June 2010
Comments Off
[UPDATED 06/08/2010] Recall classified as Class I. Various sizes of counterfeit flat sheets of polypropylene surgical mesh marketed in the U.S. labeled with the C. R. Bard/Davol brand name.
Continue reading...GammaGard Liquid, Immune Globulin Intravenous (Human)
4. June 2010
Comments Off
Market withdrawal due to an increased number of adverse event reports of allergic reactions associated with two lots.
Continue reading...
21. June 2010
Comments Off